Dr. ZHOU, Peng has more than 20 years of experience in comprehensive ophthalmology in top hospitals and specializes in the diagnosis and treatment of eye diseases, optometry examination, and external eye surgery. He has extensive experience in the treatment of myopia (nearsightedness) control, hyperopia (farsightedness), lazy eye, glaucoma, cataract, uveitis, retinal tear, diabetic retinal disorders, macular degeneration, eyelid bump, and conjunctivitis (pink eyes). He graduated with a Medical Doctor degree from Peking University and completed advanced research fellowship training in retinal diseases at the Doheny Eye Institute, University of Southern California.
周鹏医生在国内顶尖医院从事眼科临床工作二十余年，在眼科疾病的诊断与治疗、医学验光以及外眼手术方面拥有深厚的造诣。他在近视防控、远视、弱视、青光眼、白内障、葡萄膜炎、视网膜裂孔、糖尿病视网膜病变、黄斑变性、眼睑肿物以及结膜炎（红眼病）的治疗方面积累了丰富的临床经验。他毕业于北京大学并获得医学博士学位，随后在美国南加州大学Doheny眼科研究所接受了视网膜疾病的专科培训。
Dr. Zhou is a clinician-scientist at the forefront of ophthalmic research. His work focuses on myopia, cataract and age-related macular degeneration (AMD). He serves as the Principal Investigator (PI) for a National Natural Science Foundation of China project investigating age-related cataracts and was the Secretary of a National 973 Basic Research Program on AMD. His scholarly impact is recognized globally: He is the corresponding author of papers published in the prestigious Nature Communications. Furthermore, his expertise is enshrined in medical literature as he was invited by Stephen J. Ryan to author two chapters in the seminal textbook Retina (5th Edition), a standard reference in the field.
周医生是一位处于眼科研究前沿的临床科学家。他的研究工作主要集中在近视、白内障和年龄相关性黄斑变性（AMD）的发病机制与治疗。他曾担任国家自然科学基金项目（研究年龄相关性白内障）的项目负责人（PI），并曾担任科技部国家重大基础研究计划（973计划）项目的秘书。他的学术影响力得到了全球认可：他是国际顶级期刊《自然-通讯》（Nature Communications）发表论文的通讯作者。他曾受斯蒂芬·J·瑞安（Stephen J. Ryan）邀请，为该领域的权威教科书《视网膜》（Retina）第五版撰写了两个章节。
Dr. Zhou Peng has achieved numerous original breakthroughs in the field of clinical research in ophthalmology, making pioneering contributions particularly in the mechanisms of myopia control, the genetics of retinal diseases, and the epigenetics of cataracts. In the realm of myopia research, Dr. Zhou has constructed a multidimensional system for myopia prevention, control, and diagnosis. He not only originally proposed a method for calculating objective visual acuity but also became the first in the international community to reveal the initiating factor of myopia—specifically, that ciliary muscle contraction during near work leads to the elongation of the eyeball. He further elucidated the underlying cellular and molecular mechanisms through single-cell sequencing. Addressing critical clinical challenges, he identified thin corneas as a risk factor for myopia progression and constructed a myopia risk model based on this finding. Simultaneously, he established a personalized fitting formula for defocus spectacles based on ocular biometric parameters and confirmed the additive effect of visual function training in delaying myopia progression. Furthermore, he uncovered the biomechanical mechanism by which orthokeratology lenses shorten axial length and was the first to report on a novel technique combining femtosecond laser with ICL implantation for myopia treatment, offering more precise solutions for patients. Regarding fundus diseases and genetics, Dr. Zhou is dedicated to the excavation of pathogenic genes and the analysis of their mechanisms. In collaboration with his team, he made the first international discoveries of the pathogenic gene for Central Serous Chorioretinopathy (CSC) and the pathogenic gene for drusen in Age-related Macular Degeneration (AMD). In the study of the lens and cataracts, Dr. Zhou discovered and named “Sympathetic Subclinical Uveitis after Cataract Surgery,” successfully revealing its molecular mechanism.
周鹏医生在眼科领域有很多原创性成果，尤其在近视防控机制、视网膜疾病遗传学及白内障表观遗传学方面做出了开创性贡献。在近视研究领域，周医生构建了多维度的近视防控与诊疗体系。他不仅原创性地提出了客观视力计算方法，还在国际上首次揭示了近视的始动因素——即看近时睫状肌收缩导致眼球拉长，并深入阐明了其细胞与分子机制。针对临床痛点，他发现角膜偏薄是近视进展的危险因素，并据此构建了近视风险模型；同时，他建立了基于眼部生物参数的离焦眼镜个性化选配公式，并证实了视功能训练在延缓近视进展中的叠加效应。此外，他还揭示了角膜塑形镜缩短眼轴的生物力学机制，并率先报道了飞秒激光联合ICL植入术治疗近视的新技术，为近视患者提供了更精准的治疗方案。在眼底病与遗传学方面，周医生致力于致病基因的挖掘与机制解析。他与团队合作，在国际上首次发现了中心性浆液性脉络膜视网膜病变以及年龄相关性黄斑变性玻璃膜疣的致病基因。在晶状体与白内障研究中，周医生发现并命名了“白内障术后交感性亚临床葡萄膜炎”并揭示了其分子机制。
Dr. Zhou’s contributions have been honored with high accolades in the field. He is the first Mainland China doctor to receive the International Scholar Award from the American Academy of Ophthalmology (AAO) and was awarded the Distinguished Service Award by the Asia-Pacific Academy of Ophthalmology (APAO). He is a committee member of the Chinese Ophthalmology Society, an International Member of the AAO and ARVO, and serves as a reviewer for top-tier journals including Ophthalmology, American Journal of Ophthalmology (AJO), and British Journal of Ophthalmology (BJO).
周医生的贡献获得了该领域的许多荣誉。他是首位获得美国眼科学会（AAO）国际学者奖的中国大陆医生，并被亚太眼科学会（APAO）授予杰出服务奖。他是中华医学会眼科学分会的学组委员，同时也是美国眼科学会（AAO）和视觉与眼科学研究协会（ARVO）的国际会员，并担任《眼科学》（Ophthalmology）、《美国眼科学杂志》（AJO）和《英国眼科学杂志》（BJO）等顶级期刊的审稿人。
Dr. Zhou works at Parkway Xintiandi Medical Center, located at Shanghai Plaza, 138 Huaihai Rd., Shanghai. Please call 400-819-6622 or scan the QR code to make an appointment.
周鹏医生在上海黄浦区淮海中路138号百汇医疗新天地医疗中心出诊。可拨打百汇医疗24小时预约电话400-819-6622，或扫描下方二维码进行预约。
